Oruka Therapeutics, Inc.
Clinical trials sponsored by Oruka Therapeutics, Inc., explained in plain language.
-
New psoriasis drug aims for complete skin clearance
Disease control OngoingThis study is testing an experimental drug called ORKA-001 for adults with moderate-to-severe plaque psoriasis. It will compare the drug to a placebo to see if it can completely clear skin symptoms and keep them clear for up to a year. The main goal is to see how many people achi…
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
First humans receive experimental drug ORKA-002 in safety trial
Knowledge-focused OngoingThis is the very first study testing a new drug called ORKA-002 in humans. It aims to check if the drug is safe and to see how the body processes it after a single injection. The study involves about 24 healthy volunteers who will receive either the drug or a placebo. The main go…
Phase: PHASE1 • Sponsor: Oruka Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC